
For Chris Benecchi, living through the pandemic with two children suffering from depression was an entirely new level of struggle.
“It was remarkably profound,” Benecchi, chief business office of biopharmaceutical company Sage Therapeutics, told attendees Wednesday at Fortune’s Brainstorm Health conference in Marina del Rey, Calif. He spoke on a panel about the treatment of depressive disorders, hosted by Sage and Fortune Well editor Jennifer Fields.